摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(5-{4-[7-(3-dimethylamino-propoxy)-6-methoxy-quinolin-4-yloxy]-3-fluoro-phenylsulfamoyl}-4-methyl-thiazol-2-yl)acetamide | 1293292-03-1

中文名称
——
中文别名
——
英文名称
N-(5-{4-[7-(3-dimethylamino-propoxy)-6-methoxy-quinolin-4-yloxy]-3-fluoro-phenylsulfamoyl}-4-methyl-thiazol-2-yl)acetamide
英文别名
N-[5-[[4-[7-[3-(dimethylamino)propoxy]-6-methoxyquinolin-4-yl]oxy-3-fluorophenyl]sulfamoyl]-4-methyl-1,3-thiazol-2-yl]acetamide
N-(5-{4-[7-(3-dimethylamino-propoxy)-6-methoxy-quinolin-4-yloxy]-3-fluoro-phenylsulfamoyl}-4-methyl-thiazol-2-yl)acetamide化学式
CAS
1293292-03-1
化学式
C27H30FN5O6S2
mdl
——
分子量
603.696
InChiKey
ISBDGVKJWNJPQI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    41
  • 可旋转键数:
    12
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    169
  • 氢给体数:
    2
  • 氢受体数:
    12

文献信息

  • [EN] QUINOLINYLOXYPHENYLSULFONAMIDES<br/>[FR] QUINOLINYLOXYPHÉNYLSULFONAMIDES
    申请人:MAX PLANCK GESELLSCHAFT
    公开号:WO2011045084A1
    公开(公告)日:2011-04-21
    The present invention relates to quinolinyloxyphenylsulfonamides and stereoisomeric forms, solvates, hydrates and/or pharmaceutically acceptable salts of these quinolinyloxyphenylsulfonamide compounds as well as pharmaceutical compositions containing at least one of these compounds together with at least one pharmaceutically acceptable carrier, excipient and/or diluent. Said quinolinyloxyphenylsulfonamides are useful for prophylaxsis, treatment and/or after-treatment of hyperproliferative disorders, such as cancer, tumors and particularly cancer metastases.
    本发明涉及喹啉酰胺及其立体异构体形式、溶剂化物、合物和/或这些喹啉酰胺化合物的药学上可接受的盐,以及含有至少一种这些化合物和至少一种药学上可接受的载体、赋形剂和/或稀释剂的制剂。所述喹啉酰胺对于预防、治疗和/或后治疗增生性疾病,如癌症、肿瘤,特别是癌症转移,具有有用的作用。
  • QUINOLINYLOXYPHENYLSULFONAMIDES
    申请人:Ullrich Axel
    公开号:US20120277231A1
    公开(公告)日:2012-11-01
    The present invention relates to quinolinyloxyphenylsulfonamides and stereoisomeric forms, solvates, hydrates and/or pharmaceutically acceptable salts of these quinolinyloxyphenylsulfonamide compounds as well as pharmaceutical compositions containing at least one of these compounds together with at least one pharmaceutically acceptable carrier, excipient and/or diluent. Said quinolinyloxyphenylsulfonamides are useful for prophylaxsis, treatment and/or after-treatment of hyperproliferative disorders, such as cancer, tumors and particularly cancer metastases.
    本发明涉及喹啉酰胺及其立体异构体、溶剂化物、合物和/或药学上可接受的盐,以及至少包含其中一种化合物和至少一种药学上可接受的载体、赋形剂和/或稀释剂的制药组合物。所述喹啉酰胺对于预防、治疗和/或后治疗增生性疾病,如癌症、肿瘤和特别是癌症转移,具有有用的作用。
  • US9169241B2
    申请人:——
    公开号:US9169241B2
    公开(公告)日:2015-10-27
查看更多